In January 2026, Humana Inc. announced a partnership with Atlas Oncology Partners to offer more coordinated, holistic cancer care for eligible Medicare Advantage members in Tennessee and Mississippi, ...

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...

Humana, one of the two biggest players in the Medicare Advantage market, is being hit with high benefit expenses due to high utilization among its members, according to a June 16 filing with the ...

45+ Medicare companies and brands analyzed by our team of experts. 30+ years of combined experience covering Medicare and personal finance. Governed by NerdWallet's strict guidelines for editorial ...

Humana is modifying its Medicare Advantage products for 2025 amid industrywide struggles with higher costs under the program, the company announced along with its second-quarter results Wednesday.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. Humana’s ...

Humana said it raised its individual Medicare Advantage annual membership growth by 50,000 for 2024. The company reaffirmed its 2024 adjusted earnings guidance of $16 per share. See the 6X seasonal ...

The healthcare sector, led by insurance stocks, has faced chronic underperformance since 2020 as premiums fail to keep up with costs. Humana has faced significant pressures, losing over 30% of its ...

Thousands of patients insured through Humana's Medicare Advantage plans are no longer "in network" at Aultman hospitals. Adam Luntz, senior vice president of finance at Aultman, said the contract ...

Humana (HUM) has disclosed a new risk, in the Litigation & Legal Liabilities category. Humana faces a significant business risk as its Medicare Advantage plans’ Star Ratings are projected to decline ...

LOUISVILLE, Ky. — Louisville-based Humana saw its stock price take a big hit Wednesday after the healthcare company said a Medicare Advantage quality rating drop will impact future bonus payments the ...

Wednesday, Humana Inc (NYSE:HUM) posted third-quarter adjusted EPS of $4.16, down from $7.78 a year ago, beating the consensus of $3.40. The company reported revenues of $29.30 billion, up 14.7% ...